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ABSTRACT 
Toxoplasmosis, caused by the protozoan parasite Toxoplasma gondii, is one of the most common parasites 
of man and other warm-blooded animals. Humans are infected through contaminated food, water, and blood 
transfusion, organ transplantation or from mother to foetus through the placenta. Severe congenital 
infections occur as a result of primary T. gondii infection in early pregnancy. Transmission of T.gondii to the 
foetus can result in serious health problems, including mental retardation, seizures, blindness and death. 
Frequency of foetal infection is higher when maternal infection occurs later in pregnancy and sequelae are 
more severe when maternal infections occur early in the first trimester of pregnancy. The ability of the 
parasite to survive intracellularly largely depends on the blocking of different proapoptotic signaling 
cascades of the host cells. During pregnancy, however, alterations in the incidence of apoptosis are 
associated with abnormal placental morphology and function. Both cellular and humoral immune responses 
control T.gondii infection. Toxoplasma is asymptomatic, infected women can only be detected by serological 
testing. In many instances, congenital toxoplasmosis can be prevented by educating pregnant women and 
women of childbearing age about the route of transmission. The need for screening suspected cases of T. 
gondii will help reduce transmission to the foetus.  
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INTRODUCTION 
Toxoplasma gondii is an intracellular coccidian 
parasite that belongs to the phylum Apicomplexa. 
The parasite is globally distributed and can be 
found within many different species of mammals 
and birds. It is an obligate intracellular parasite 
with properties similar to the pathogen that 
causes malaria. T.gondii infects a large proportion 
of the world’s population but uncommonly causes 
clinically significant disease.  Toxoplasmosis is 
usually an asymptomatic disease, but often takes  
 
a severe and life threatening course during 
pregnancy, in foetuses, new born babies, and in 
immunocompromised patients (Robert-Gangneux 
et al., 2009). Most cases of toxoplasmosis in the 
immunocompetent hosts are subclinical or 
benign. The most severe symptoms occur in the 
congenitally acquired form and in immune 
deficient individuals. Toxoplasmosis in 
immunocompetent host can be classified as 
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Foetal infection with T. gondii may result in 
stillbirth or abortion. Congenital infection is most 
severe if acquired in the first or, in some cases, 
second trimester of pregnancy. Infection during 
the second or third trimester tends to be 
asymptomatic. It may lead severe CNS 
impairment, which might not manifest for several 
years. Infection in children without evidence of 
exposure to T. gondii has been recorded (Varella 
et al., 2009). Domestic cats are the definite host 
of T.gondii. Infected faeces of cats containing the 
oocysts contaminate the food of man thus 
commencing the life cycle. Toxoplasma gondii life 
cycle has three forms: tachyzoite, bradyzoite, and 
sporozoite. During the acute stage of T.gondii 
infection, tachyzoites invade and replicate within 
cells and are responsible for congenital infection. 
The tachyzoites invade all organs, especially the 
muscle (including the heart) liver, spleen, lymph 
nodes and central nervous system (CNS).  During 
the latent infection, bradyzoites are present in 
tissue cyst. Sporozoites are found in 
environmentally resistant oocyts formed after the 
sexual stage of life cycle.   
 
Patients with acquired toxoplasmosis can present 
with a range of clinical manifestation, from 
subclinical lymphadenopathy, which is the most 
common presentation, to fatal, fulminant disease. 
In the immunocompetent host, infection with T. 
gondii may be indistinguished from infectious 
mononucleosis (Hoeprich et al., 1994). Clinically 
reactivated toxoplasmosis is usually due to the 
reactivation of latent T. gondii infection; therefore 
all AIDS patients with T. gondii antibodies are at 
risk of developing active infection (Hoeprich et al., 
1994). In most African countries, sufficient 
attention is yet to be given to toxoplasmosis. 
Therefore, this review highlights the pathology of 
congenital toxoplasmosis and other forms of 
toxoplasmosis, immune-response and current 
treatment options. 
 
PREVALENCE OF TOXOPLASMOSIS AND 
MODE OF TRANSMSSION 
Toxoplasma gondii infection is widespread in 
humans although its prevalence varies widely 
from place to place and it is estimated that up to 
fifty million people worldwide are infected. Overall, 
less than 0.1% of the general population has been 
studied to be infected congenitally (Choi et al., 
1997; Evengard et al., 1999). Reported birth  
 
 
prevalence with congenital toxoplasmosis ranges 
from one to ten per 10,000 live births (Evengard 
et al., 2001). There has been an increase in 
seroprevalence to Toxoplasma antibodies among 
pregnant women in Cali, Colombia, for the past 
25years (Rosso et al., 2008). Toxoplasma 
antibody serological tests using the Dye test on 
sera of pregnant and postpartum Nigerian women 
showed prevalence rates that ranged from 72.5% 
to 88.8% (with an overall rate of 75.4%), and 
75.0% to 94.4% (with an overall rate of 80.5%) 
respectively (Onadeko et al., 1996).  
 
Toxoplasma gondii is transmitted by three 
principal routes.  First, human can acquire 
T.gondii by eating raw or inadequately cooked 
infected meat, especially pork, mutton, and wild 
game, or uncooked foods that have come in 
contact with infected meat (Dubey, 1994). 
Second, humans can inadvertently ingest oocysts 
that cats have passed in their faeces, either from 
a litter box or from soil (e.g. soil from gardening, 
unwashed fruits or vegetables in unfiltered water). 
Third, women can transmit the infection 
transplacentally to their unborn foetus. 
Transplacental infection occurs when an 
uninfected mother acquires infection during 
pregnancy. First, there is a parasitaemia in the 
mother, the invasion of placenta, and finally T 
gondii spreads to foetal tissues. Transmission of 
T.gondii may also occur through blood 
transfusions and organ transplants.  Oocysts 
contamination of the environment is widespread 
as oocysts are shed by domestic cats and other 
members of the Felidae (Dubey and Beattie, 
1988). Domestic cats are probably the major 
source of contamination since oocysts formation 
is greater in domestic cats. Cats may excrete 
millions of oocysts after ingesting only one 
bradyzoite or one tissue cysts, and many tissue 
cysts may be present in one infected mouse 
(Dubey, 2001). 
 
Toxoplasma gondii is common in many animals 
used for food, including sheep, pigs and rabbits. It 
may survive in food animals, in tissue cysts for 
years (Hill and Dubey, 2000). Virtually all-edible 
parts of an animal can harbour viable T.gondii. 
Viable T.gondii infection was isolated from 17% of 
1000 adult pigs from a slaughter plant in Iowa 
(Dubey and Odening, 1995). Toxoplasma 
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in serological survey carried out in Kano, Nigeria 
(Okoh et al., 1981). The largest outbreak of  
 
clinical toxoplasmosis in humans was 
epidemiologically linked to drinking water from a  
municipal water reservoir in British, Columbia, and 
Canada (Isaac-Renton et al., 1998). The water 
reservoir was thought to be contaminated with 
T.gondii oocysts excreted by cougars (Felis 
concolor) (Aramini et al., 1999). The cultural 
habits of a population have been known to affect 
the acquisition of T.gondii infection from ingested 
tissue cysts in undercooked meat. French habit of 
eating some meat products raw or undercooked 
led to high incidence of T.gondii infection in 
humans in France (Dubey, 1988). 
 
Toxoplasma gondii Genotypes and Pathology  
Worldwide genotypic analysis of T.gondii isolates 
identified population structure consisting of three 
widespread clonal lineages termed type I, II and 
III (Howe and Sibley, 1995; Ferreira Ade et al., 
2006). It was proposed that the different 
genotypes may be partly responsible for the 
different pathogenicities observed in the infection 
as Type II strains are known to have overall 
prevalence in human infections, whereas type I 
strains are over represented in studies of 
congenital toxoplasmosis (Howe and Sibley, 
1995). Type I strains in mice, were noticed to 
rapidly disseminate and reach high tissue burden 
even from very low initial inoculums, and it was 
reported to be the most virulent (Mordue et al., 
2001). The abundance of type I and recombinant 
strains in patients with retinochoroiditis have been 
seen in Brazil (Ferreira Ade et al., 2006). In 
addition, type I and III strains were observed to be 
the cause of ocular disease (Ferreira Ade et al., 
2006). The enhanced ability in type I strains to 
cross biological barriers likely represents an 
important advantages in the establishment of 
disseminated infection. However, both pathogenic 
and apathogenic isolates have been observed in 
a study in Brazil belonging to genotype I (Peyron 
et al., 2006).  
 
The ability of the parasite to survive intracellularly 
largely depends on the blocking of different 
proapoptotic signaling cascades of the host cells. 
During pregnancy, however, alterations in the 
incidence of apoptosis are associated with 
abnormal placental morphology and function. In a 
study to evaluate the incidence of apoptosis and 
cell proliferation in trophoblastic (BeWo cell line) 
and uterine cervical (HeLa cell line) cells infected 
with a highly virulent RH strain or a moderately 
virulent ME49 strain of T. gondii. Angeloni et al. 
(2009) reported that RH and ME49 strains of T. 
gondii possess opposing mechanism of 
interference in apoptosis and cell cycle S phase of 
both BeWo and HeLa cells and these differences 
can be associated to evasion strategies of the 
parasite to survive inside the host cells. In 
humans, clinical disease is normally limited either 
to immunocompromised individuals or to 
congenital disease resulting from an acute 
infection of the expectant mother. The severity of 
congenital infections depends on the stage of 
pregnancy when the acute infection occurred, and 
spontaneous abortions or neurological disorders 
such as blindness and mental retardation could 
occur (Black and Boothroyd,  2000).  
 
Toxoplasma gondii has the ability to invade and to 
establish productive infection in almost all 
nucleated cell. The initial step of the parasite 
invasion process is recognition and attachment to 
the target cell. Upon encountering the host cell, 
the parasite will survey the membrane until an 
appropriate point of attachment is recognized by 
the apical pole. Host cell lamini, parasite surface 
lectins and major parasite surface protein may 
participate in preliminary attachment of parasite to 
host cell (Kasper and Mineo, 1994). Two types of 
organelle (rhopteries and micronemes) at the 
anterior end of the parasite appear to be involved. 
Rhopteries are found to be discharged at the time 
of invasion while micronemes may discharge their 
contents immediately preceding or during invasion 
(Manger et al., 1998). Two microneme proteins 
that contain thrombospondin-like domains may 
function in adherence following their release on 
the surface of the parasite (Wan et al., 1997). 
 
The effect of Toxoplasma infection on any given 
person may differ, depending on factors such as: 
individual genetic predisposition, the state of the 
immune system, the parasite doses, the virulence 
of the infecting strain, the timing of infection (e.g. 
infection in the first trimester, prenatal and 
postnatal infections) and the part of the brain 
affected (Singh et al., 1998; Torrey and Robert, 







acquired toxoplasmosis is more severe than 
postnatal acquired infection (Singh, 2003). Some 
sequelae of congenital toxoplasmosis are not  
apparent at birth and may not become apparent 
until the second or third decade of life (Torrey and 
Robert, 2003). Therefore, the severity and 
likelihood of infection is dependent on the 
trimester of pregnancy and if the mother has 
became infected with T.gondii. The severity of 
toxoplasmosis infection in an infant whose mother 
becomes infected during the first trimester is 
higher than during the third trimester (Singh, 
2003). Symptomatic infants present with a 
combination of fever, microcephaly or 
hydrocephalus, hepatosplenomegaly, jaundice, 
chorioretinitis and seizures. Pneumonitis, 
myocarditis, thrombocytopenia, mono and 
lymphocytosis, and a maculopapular rash are also 
known to occur (Martin, 2000).  Children may be 
asymptomatic with sequelae such as 
chorioretinitis, mental retardation, seizures and 
nerve palsies during the neonatal period (Peyron 
et al., 1996). Chorioretinitis has been reported to 
occur later in life in some infants and this has also 
been discovered in adolescence (Peyron et al., 
1996). 
 
Toxoplasma initially crosses the intestinal 
epithelium, disseminates into the deep tissue, and 
transverses biological barriers such as the 
placenta and the blood brain barrier to reach 
immunologically privileged sites where it causes 
the most severe pathology. Varieties of cell types 
including intra epithelial leucocytes in the intestine 
are known to be invaded during histopathological 
studies of Toxoplasma (Dubey et al., 1997). 
Crossing biological barriers, including the 
intestine, the blood barrier and the placenta, 
leading to dissemination within the host is a 
prerequisite for the establishment of T.gondii 
infections. Ingested parasites (oocysts or 
bradyzoite in tissue cysts) invade the intestine 
and differentiate into tachyzoites followed by 
spread of the organism haematogenously and via 
lymphatic tissue (Dubey, 1997). Tachyzoites are 
known to play important role in the pathogenesis 
of acute toxoplasmosis (Robert and Mcleod, 
1999) and in reactivation of chronic infection in 
human (Reiter et al., 2000). 
 
Toxoplasma crosses epithelial barriers to gain 
access to deeper tissues including the brain, the  
 
 
Sierra Leone J Biomed Res  2009| Vol. 1 No. 1 12 
placenta and the retina. Toxoplasma tachyzoites 
use active motility to cross polarized cell layers 
and extracellular matrix (Howe and Sibley, 1995). 
This suggests that active parasite migration is an 
important component of dissemination during 
toxoplasmosis. Active motility is not only used for 
cell invasion but also provide the parasite with an 
effective mechanism of dissemination in its micro 
environment within tissues (Howe and Sibley, 
1995). Although most congenitally infected 
children are asymptomatic at birth, they may 
develop some symptoms later in life. 
Hydrocephalus, chorioretinitis, intracerebral 
calcification, pancytopenia, and death may occur 
(Remington et al., 1995; Singh et al., 1998). Loss 
of vision was reported to be the most common 
sequela in congenitally infected children 
(Remington et al., 1995).  
 
There are indications that most ocular disease 
from T.gondii is caused by infection after birth.  
Silveria et al. (2001) showed that ocular 
toxoplasmosis is due to acute infection after birth 
because the rate of infection in young children 
was low. Although, postnatally acquired infections 
were reported to be asymptomatic, manifestations 
of toxoplasmosis include large lymph nodes 
(particularly of the cervical region) headaches, 
muscles aches and sore throat (Hunter and 
Remington, 1994). Subclinical forms of 
toxoplasmosis have also been observed in 
children at birth, without higher incidence of 
prematurity or low weight at birth. The main 
neurological sequela observed among the 
children was a delay in their neuro-psychomotor 
development (Safadi et al., 2003).  
 
When infection occur for the first time during 
pregnancy, mother to child transmission of the 
parasite could cause congenital toxoplasmosis. 
The risk of transmission depends on the gestation 
at maternal infection, rising from approximately 
6% for women infected at 10 weeks of gestation 
to 80% if the infection occurred at 38 weeks 
(Dunn et al., 1999). Transplacental passage is 
more common when maternal infection occurs in 
the latter half of pregnancy, but foetal injury is 
usually less severe. It may lead to miscarriage, 
stillbirth, or congenital defects depending on the 
stage of gestation when the infection occurs 
(Gagne, 2001). Robert et al., (1999) reported that 
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maternal infection occurs later in the pregnancy 
(e.g. third trimester). Most children with congenital 
toxoplasmosis appear developmentally normal but 
up to 3% have evidence of permanent 
neurological damage or bilateral visual 
impairment (Dunn et al., 1999). Placental 
contamination is a pre-requisite to congenital 
infection when there is maternal parasitaemia. 
The infected placenta then acts as a reservoir 
from which the parasite can spread to the foetus 
leading to multi-systemic disease (Daffos et al., 
1988). 
 
Toxoplasmosis is known to be a lifelong condition. 
When the mother is chronically infected with 
T.gondii, the parasite is dormant in maternal 
tissues and there is no parasitaemic phase. 
Foetal transmission can occur immediately after 
maternal infection or be delayed by weeks 
(Martins, 2000). Toxoplasma infection in early 
pregnancy leads to miscarriage or intra-uterine 
death. In foetuses that survive, lesions are 
predominantly cerebral due to cerebral vasculitis 
and necrosis. The earlier the infection occurs in 
pregnancy, the worse the outcome is for the 
foetus, both in term of survival and sequelae, 
(Martins, 2000). Women who are seropositive 
before conception have the least risk of congenital 
toxoplasmosis while the greatest risk of congenital 
toxoplasmosis occurs during the first trimester of 
pregnancy (Remington et al., 1995; Evengard et 
al., 1999). However, the highest level of 
transmission of congenital toxoplasmosis occurs 
in the third trimester. This is thought to be related 
to the much larger size of the uterus. If a woman’s 
foetal loss is as a result of T.gondii infection; her 
subsequent pregnancies are safe as far as the 
parasitic infection is concerned until she becomes 
immunocompromised during subsequent 
pregnancies.  
 
Although, transmission of congenital 
toxoplasmosis by an immunocompetent woman 
infected before conception, to her foetus had 
been reported (Villena et al., 1998). Practically, 
only mothers with primary infection acquired 
during pregnancy are known to be at risk. If the 
infection was acquired before conception, there is 
no practical risk of congenital transmission 
(Martins, 2000).  
 
However, a T. gondii strain involved in re-infection 
was isolated, characterized, and studied in an  
 
experimental mouse model that suggested 
immunity against type II strain may not be 
protective against a re-infection with a different 
genotype, especially if it is atypical (Elbez-
Rubinstein et al., 2009). 
 
Congenital Toxoplasmosis: Severity of Foetal 
Disease 
The severity of foetal disease varies inversely with 
the gestational age at which maternal infection 
occurs.  
Without Toxoplasma-specific chemotherapy, most 
foetuses infected early in pregnancy die in uteri or 
in the neonatal period, or have severe neurologic 
and ophthalmologic disease (Lynfield and 
Guerina, 1997). Nearly all foetuses infected in the 
second and third trimesters have mild or 
subclinical disease in the newborn (Lynfield and 
Guerina, 1997). The principal clinical findings for 
infants and children who had symptomatic 
infection invariably had some degree of central 
nervous system (CNS) involvement and often had 
significant retinal disease.  Approximately two 
thirds of them had disease primarily limited to the 
CNS and eyes; one third had more generalized 
findings. Infants who had primary neurologic 
disease typically had intracranial calcifications, 
abnormal cerebrospinal fluid (CSF) profiles, 
chorioretinitis, and convulsions. Infants who had 
signs and symptoms of generalized disease had 
hepatosplenomegaly,lymphadenopathy,hyperbilir
ubinaemia, and anaemia in addition to CSF 




Toxoplasma gondii is the most common cause of 
infectious chorioretinitis in immunocompetent 
children and adults. It is also an important cause 
of ocular disease in immunocompromised patients 
(Peyron et al., 1996). Most cases are believed to 
result from local reactivation of congenital 
infection, but high rates of chorioretinitis have 
been described to be due to postnatally acquired 
toxoplasmosis (Lynfield and Guerina, 1997). 
Acute Toxoplasma chorioretinitis is usually 
subclinical in healthy children and adults, but 
severe complications, including visual impairment 
or glaucoma, may occur in some cases (Lynfield 
and Guerina, 1997). Several mechanisms for 
onset of retinal disease in congenital infection 
have been proposed, including invasion of the eye 






inflammatory reaction to old retinal tissue cysts, 
and a hypersensitivity reaction to Toxoplasma 
antigens localized in the retina. The peak 
incidence of relapsing chorioretinitis following 
congenital infection is in the second and third 
decades of life (Lynfield and Guerina, 1997). 
 
Toxoplasmosis in the Immunocompromised 
Host 
Two types of infection are seen: recrudescent 
chronic infections, occurring in patients with 
Toxoplasma antibody and AIDS (acquired 
immunodeficiency syndrome) and severe primary 
infection.  
 
Rupture of cysts in immunocompromised hosts 
result in disease reactivation, including 
encephalitis or disseminated toxoplasmosis 
(Jones et al., 2003). Chronic toxoplasmic 
encephalitis may occur when a person’s immune 
system is impaired. Indeed, toxoplasmic 
encephalitis marked by dementia and seizures 
has become the most commonly recognized 
cause of central nervous system opportunistic 
infections in AIDS patients. Additionally, it 
appears that certain cancer treatments weaken 
the immune system and old infections in the 
muscles could become reactivated, causing 
severe complications or death (Shirttematter et 
al., 1992). Most cases are relapses of chronic 
infections, caused by AIDS or 
immunosuppressive drugs that impair cellular 
immunity, especially corticosteroids and 
cyclophosphamide. 
 
Primary infections occur in immunosuppressed 
patients by natural routes, by heart transplant, or 
leukocyte transfusion. They involve many organs, 
and tend to be more severe. The usual 
predisposition factors are in patient receiving 
immunosuppressive drugs, and rarely, early 
undiagnosed leukemia, lymphoma, or AIDS 
infection. Patients with such impaired immunity 
are likely to experience reactivation of latent 
disease than to acquire new infections (Pedrol et 
al., 1990). The increasing use of highly 
immunosuppressive chemotherapy and 
conditioning regimens (including rituximab, 
fludarabine and anti-thymocyte globulin) was 
reported to be associated with a significant risk of 
toxoplasmosis in patients after allogeneic  
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haematopoietic stem cell transplantation (HSCT) 
(Rusiňáková et al., 2009). 
 
IMMUNE RESPONSE TO CONGENITAL 
TOXOPLASMOSIS 
The immune system has a crucial role in both the 
course of the infection and in the evolution of 
toxoplasmosis disease. In particular, IFN-gamma 
plays an important role in resistance to 
toxoplasmosis. Polymorphisms in genes encoding 
cytokines have been shown to have an 
association with susceptibility to parasitic 
diseases (de Albuquerque et al., 2009). Natural 
immunity against T.gondii is dependent on the 
induction of strong parasite specific immunity in 
the host (Sher et al., 1995). The rapid migration of 
neutrophils to site of infection is thought to be 
important for parasite control before adaptive 
immunity is established (Del Rio et al., 2001). 
Toxoplasma actively infects leukocytes in vitro 
and tachyzoites have also been identified within 
leukocytes in the murine intestine (Dubey et al., 
1997; Channon et al., 2000) and therefore the 
presence of leukocytes may have contributed to 
the dissemination of intracellular parasites (Shaw 
et al., 1998).   
 
CD8+ and/or CD4+ T cells play synergistic role in 
the acquisition of protective immunity against 
Toxoplasma infection. Immune CD8+ T cells from 
both infected mice or human secretes interferon 
gamma (IFN-γ) and exhibit invitro cytotoxicity 
towards infected cells (Khan et al., 1990). T-
helper (Th-1) CD4+ T cells produce IFN-γ and IL-
12, while T-helper (Th-2) cells produce IL-4, IL-5 
and IL-10 which are associated with down 
regulation of parasitic cell mediated immune 
response (Mosmann and Moore, 1991). The roles 
of natural killer cells (NK) and IFN-γ were shown 
to reduce maternal infection, perhaps because of 
inhibition of tachyzoite replication. Also increased 
in number of killer cells in mice partially protects 
against congenital Toxoplasma transmission 
(Remington et al., 1995). 
 
Both cellular and humoral immune response 
control parasite virulence and tissue tropism 
which may be strain specific. Macrophages are 
involved in the regulation of cellular immunity 
through their production of immunologic 
mediators. Tachyzoites stimulate macrophages to 
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activates NK cells and T-cells to produce 
interferon gamma and it is this early produced 
interferon-gamma that is crucial for resistance. 
The combination of IFN-γ and tumour necrosis 
factor (TNF) meditate killing of tachyzoites by 
macrophages (Kahn et al., 1996). The production 
of nitric oxide may however, have opposing 
effects. Nitric oxide production protects against T. 
gondii infection and at the same time limits the 
immune response probably contributing to the 
establishment of the chronic state (Hayashi et al., 
1996).  
In a recent study by Matowicka-Karna et al. 
(2009) that evaluated Th2 humoral response (IL-
5, IL-6, IL-10) and Th1 cell response (IL-12, TNF-
alpha) in patients infected with T. gondii, they 
reported twofold higher levels of IL-5 and IL-6 as 
compared to healthy subjects, which seemed to 
confirm the presence of an inflammatory state. 
They also found that the level of IL-10 was fivefold  
higher in the course of toxoplasmosis than in 
healthy controls. The levels of IL-12 and TNF-
alpha were comparable to those observed in 
healthy controls. The study thus revealed that 
patients infected with T. gondii showed increased 
production of the humoral response cytokines, 
whereas the generation of the cell response 
cytokines remained unchanged (Matowicka-Karna 
et al., 2009). 
The analyses of the occurrence of polymorphisms 
in the gene encoding IFN-gamma (+874T/A) 
among Toxoplasma gondii seropositive 
individuals, including those with ocular lesions 
caused by the parasite was conducted by de 
Albuquerque et al. (2009) so as to verify the 
polymorphisms that could be related to 
susceptibility to the development of ocular 
toxoplasmosis. They reported that the differences 
between A and T allele distributions were not 
statistically significant between the two groups. 
However, it was observed that a higher frequency 
of individuals from the ocular group possessed 
the A/A genotype, when compared with the 
control group, suggesting that homozygocity for 
the A allele could enhance susceptibility to ocular 
toxoplasmosis in T. gondii infection (de 
Albuquerque  et al., 2009). 
 





When toxoplasmosis infection is suspected in a 
woman during pregnancy or before pregnancy, 
the diagnosis is primarily made by serological 
investigation (Pinon et al., 2001). Detection of 
Toxoplasma specific antibodies is the primary 
diagnostic method in determining the parasite 
infection.  Different serological tests have been 
used to detect antibodies to the parasite. T.gondii 
specific IgG, IgM, IgA or IgE antibodies can be 
detected with the serological methods. Newborn 
infants suspected of congenital toxoplasmosis 
should be tested by both an IgM and IgA capture 
enzyme immunoassay. In cases of congenital 
infection, however, antibody responses may be 
delayed in some infants, and the presence of 
transplacentally transferred maternal IgG may 
interfere further with the serologic confirmation of 
infection. For these reasons, all infants known to 
be at risk for congenital infection should be 
evaluated further for clinical signs of infection 
(chorioretinal lesions, intracranial calcifications, or 
hydrocephalus) (Lynfield and Guerina, 1997). 
Classically, serodiagnosis includes titration of 
specific immunoglobulin G (IgG) showing past 
exposure and screening for specific IgM, which is 
suggestive of recent exposure or ongoing active 
infection. IgM detection could be due to naturally 
interfering IgM or persistence of IgM for long time 
after primary infection (Suzuki et al., 2001). 
Toxoplasma infection can also be detected with 
the use of polymerase chain reaction (PCR) test 
for DNA determinants. PCR is most often used in 
testing the amniotic fluid to determine whether the 
foetus of an infected pregnant woman is infected 
(Jones et al., 2003).  
 
Screening during pregnancy is of importance in 
preventing congenital infections and in diagnosing 
all infected infants. Since most congenitally 
infected infants appear normal at birth, screening 
for toxoplasmosis is helpful in identifying women 
who are non-immuned at the beginning of their 
pregnancy. Screenings for presence of antibodies 
allow primary prevention of toxoplasmosis 
infection where eating habit and hygiene practices 
have been identified as risk factors (Martins, 
2000). All suspected patients should be initially 
tested for presence of Toxoplasma specific IgG 
antibodies to determine their immune status. 
Presence of IgG antibodies only signify exposure 
because asymptomatic humans can develop very 
high T.gondii antibody titers and titer may remain 






repeated exposures are encountered. Recent 
infection can be identified by an 8-fold rise in 
antibodies titer; taken two weeks apart (Pinon et 
al., 2001). 
 
Sulphadiazine and pyrimethamine are the two 
drugs that are widely used for the treatment of 
toxoplasmosis. These drugs have beneficial effect 
on toxoplasmosis when given in the acute stage but 
when there is active multiplication of the parasites, 
they will usually not eradicate infection (Guerina et 
al., 1994). The employment of combined drugs is 
known to be principally effective on the actively 
multiplying tachyzoites. When infection in uteri is 
documented using PCR on an amniotic fluid 
sample, the mother should be started on a 
combination of pyrimethamine and sulphadiazine 
with folinic acid supplementation. Good outcome 
has been reported with the use of high-dose 
pyrimethamine, clindamycin, co-trimoxazole and 
folic acid in patients after allogeneic haematopoietic 
stem cell transplantation (HSCT) (Rusiňáková et 
al., 2009).  
Infected infants should be treated after birth up to 
one year of age with the same drugs whether the 
infection is over or latent and follow up is important 
up to adolescence (Martin, 2000).  
Severe ocular forms of toxoplasmosis are also 
usually treated with the standard regimen but 
sulfadiazine may be substituted by clindamycin. 
The preferred treatment in immunocompromised 
patients is the standard combination of 
pyrimethamine and sulfadiazine. However, due to 
frequent serious side effects, alternative 
treatments are possible. In some patients, 
especially those undergoing immunosuppression 
due to stem cell transplantation, primary 
prophylaxis of cerebral toxoplasmosis is achieved 
by co-trimoxazole. Reduced doses of the 
standard regimen may be used as secondary 
prophylaxis during severe immunosuppression in 
these patients. However, due to an increased risk 
of myelotoxicity, other therapeutic measures have 
to be used (Prášil, 2009). 
 
PREVENTION OF TOXOPLASMA INFECTION 
IN WOMEN 
Proper washing of hands after handling meat, 
poultry or seafood with soap and water before 
doing other task will prevent Toxoplasma infection 
in human beings. (Dubey and Beattie,1988). It is  
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also important for pregnant women to wear gloves 
when they are gardening or touching soil or sand, 
because of possible presence of cat faeces. 
Afterwards they should wash their hands 
thoroughly (Jones et al., 2003). Healthcare 
workers should educate women of childbearing 
age on information about T.gondii transmission. 
At the first prenatal visit, health care provider 
should educate pregnant women about food 
hygiene and if possible, pregnant women should 
avoid exposure to cat faeces (Jones et al., 2003).  
In the last few years, there has been considerable 
progress towards the development of a vaccine 
for toxoplasmosis, and a vaccine based on the 
live-attenuated S48 strain was developed for 
veterinary uses (Kur et al., 2009). However, this 
vaccine is expensive, causes side effects and has 
a short shelf life. Furthermore, this vaccine may 
revert to a pathogenic strain and, therefore, is not 
suitable for human use. Various experimental 
studies have shown that it may be possible to 
develop a vaccine against human toxoplasmosis 
(Kur et al., 2009).  
 
IMPLICATIONS FOR CURRENT PRACTICE 
AND FURTHER RESEARCH  
Presently, there is no evidence of prenatal 
screening or neonatal screening in Nigeria and in 
most African countries. This issue needs to be 
revisited to prevent morbidity and mortality due to 
toxoplasmosis especially considering the 
pathology due to toxoplasmosis. This is 
imperative in settings where domestic cats are 
common. Further research is needed to determine 
the risk of neurological or visual impairment in 
infected children and whether the risk or severity 
of impairment can be reduced by prenatal or 
postnatal treatment.  
 
Serological screening for specific antibodies to 
Toxoplasma will reduce the transmission of 
toxoplasmosis to foetus. Women with HIV 
infection should be screened for toxoplasmosis 
because of the risk of T. gondii reactivation and 
toxoplasmic encephalitis (Jones et al., 2003). 
Reliable information is needed on the prevalence 
of the disease in most African countries. Mortality 
and morbidity due to postnatally acquired 
toxoplasmosis, both in immune competent and 
deficient people far exceeds the burden of the 
disease due to congenital toxoplasmosis (Gilbert 
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Primary prevention of toxoplasmosis in the 
general population may have a much greater 
impact on the morbidity and mortality due to 
toxoplasmosis than strategies confined to 
pregnant women. Primary prevention is needed to 
tackle major sources of infection such as infected 
meat and meat products (Cook et al., 2000). 
 
CONCLUSION 
The clinical manifestation of congenital 
transmission includes: chorioretinitis, 
hydrocephalus and intracranial infection. T gondii 
acquired during pregnancy may be transmitted to 
the foetus and may cause inflammatory lesions 
that may lead to permanent neurological damage, 
with or without hydrocephalus, and chorioretinitis 
with visual impairment. Congenital toxoplasmosis 
is an important cause of morbidity and mortality 
among immunocompromised patients and can 
cause foetal infection with unpredictable 
manifestations in the foetus and neonate if it is 
acquired during pregnancy. Toxoplasmosis can 
lead to severe sequelae for the foetus and the 
newborn with death. Sequelae are more severe 
when maternal infection occurs early in first 
trimester. Frequency of foetal infection is higher 
when maternal infection occurs later in 
pregnancy.  
 
Pregnant women and the infected newborns are 
often asymptomatic though they stand the risk of 
having recurring chorioretinitis later in life. 
Toxoplasma gondii infections in pregnancy should 
be a notifiable disease for clinicians and 
researchers in African countries. Follow-up of 
infected children should be performed as part of a 
quality control programme of screening. Women 
should be enlightened on how to avoid 
Toxoplasma infection. Prospective and 
randomised trials are also needed to properly 
manage congenital toxoplasmosis. 
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